Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure.
Saved in:
| Title: | Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure. |
|---|---|
| Authors: | Ebmeyer J; Beiersdorf AG, Hamburg, Germany., Najjar A; Beiersdorf AG, Hamburg, Germany., Lange D; Beiersdorf AG, Hamburg, Germany., Boettcher M; Beiersdorf AG, Hamburg, Germany., Voß S; Beiersdorf AG, Hamburg, Germany., Brandmair K; Beiersdorf AG, Hamburg, Germany., Meinhardt J; Beiersdorf AG, Hamburg, Germany., Kuehnl J; Beiersdorf AG, Hamburg, Germany., Hewitt NJ; Cosmetics Europe, Auderghem, Belgium., Krueger CT; Beiersdorf AG, Hamburg, Germany., Schepky A; Beiersdorf AG, Hamburg, Germany. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Mar 07; Vol. 15, pp. 1345992. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
